Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.3B | 2.1B | 1.9B | 2.2B |
| Cost of revenue | 1.1B | 1.0B | 979M | 1.1B |
| Gross profit | 1.2B | 1.1B | 970M | 1.1B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 248M | 240M | 199M | 240M |
| Operating income | 214M | 208M | 188M | 223M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 205M | 209M | 177M | 221M |
| Tax provision | 39M | 54M | 32M | 36M |
| Net income | 166M | 154M | 146M | 185M |
| Basic EPS | 1.8 | 1.7 | 1.6 | 2.0 |
| Diluted EPS | 1.8 | 1.7 | 1.6 | 2.0 |
| Basic average shares | 996.7M | 996.7M | 996.7M | — |
| Diluted average shares | 1.0B | 999.6M | 999.6M | 999.6M |
| EBITDA | 296M | 291M | 263M | 296M |
| Net income from continuing op. | 205M | 209M | 177M | 221M |
| Minority interests | 0 | 0 | 0 | -1M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |